MyBioSource

Executive Summary

MyBioSource is a US-based life science reagent supplier founded in 2004 and headquartered in San Diego. The company offers a broad portfolio of research tools, including antibodies, proteins, ELISA kits, and assay reagents, primarily serving academic, biopharmaceutical, and diagnostic research sectors. As a critical supplier in the global research supply chain, MyBioSource enables basic and applied biomedical research. With over two decades of operation, the company has established a reliable presence in the highly competitive reagents market, though its scale and growth trajectory remain opaque due to its private status and lack of disclosed funding or valuation data. The company's profile on platforms like BiopharmGuy suggests it is a steady, undifferentiated player in a fragmented industry, with no recent catalysts reported. However, its long-standing tenure implies a resilient business model and recurring demand from institutional customers.

Upcoming Catalysts (preview)

• TBDExpansion into high-growth areas such as CRISPR reagents or cell therapy tools via new product launches40% success
• TBDStrategic partnership or distribution agreement with a major biopharma or academic consortium to expand market reach35% success
• TBDPotential acquisition by a larger life science tools company seeking to broaden catalog offerings25% success